Most insurance plans will cover either all or a portion of the treatment.
Content Reviewed By:
SUD treatment executive, national news contributor & keynote speaker.
Navigation:
- Overview
- What Is Ibogaine?
- What Conditions Can Ibogaine Be Used to Treat?
- Side Effects of Ibogaine
- Ibogaine’s Potential Benefits in Addiction Treatment
- International Ibogaine Clinics
Overview
Ibogaine is one of several psychedelic substances currently being studied for the treatment of substance use disorders and other mental health conditions. Although traditional psychedelics are not currently FDA-approved for clinical treatment in behavioral health, a growing body of research suggests that certain psychedelic substances may have therapeutic potential for various mental health conditions.
Recent federal actions, including the FDA’s initiative to accelerate treatments for serious mental illness, aim to advance research and regulatory reviews for serious conditions such as post-traumatic stress disorder (PTSD) and depression. Currently, ketamine is used off-label for certain mental health conditions, while the FDA-approved nasal spray esketamine (Spravato) is authorized for specific depressive disorders. Neither treatment constitutes FDA approval of traditional psychedelics.
To reiterate, ibogaine is not FDA-approved for any medical use in the United States and is classified as a Schedule I controlled substance under federal law. Its manufacture, possession, and distribution are generally prohibited outside authorized research. Ibogaine treatment is offered in certain other countries, including Mexico, although regulatory requirements and clinical oversight vary by location.
What Is Ibogaine?
Ibogaine is a naturally occurring psychoactive substance derived from the African plant Tabernanthe iboga. The plant grows wild in tropical African countries such as Gabon, the Republic of the Congo, and Angola. Researchers and individuals who have used ibogaine report that it can produce an intense, long-lasting, dream-like state that may persist for 12 to 36 hours, with some effects lingering longer. In the United States, its lawful administration is generally limited to specifically authorized research settings.
Ibogaine is also being studied for its potential effects on neuroplasticity—the brain’s ability to reorganize itself, form new neural connections, and adapt to changing circumstances. However, the extent and clinical significance of these effects in humans remain under investigation.
What Conditions Can Ibogaine Be Used to Treat?
Although ibogaine is not currently approved to treat any medical or psychiatric conditions in the United States, preliminary research suggests that it may have therapeutic potential for several conditions, including:
- Traumatic Brain Injury (TBI) – Preliminary research suggests that ibogaine may be associated with reductions in certain symptoms and improvements in cognitive functioning, including concentration, memory, processing speed, and executive function. However, larger controlled studies are needed to establish its effectiveness and safety.
- Depression and Trauma – Early studies suggest that ibogaine may help reduce symptoms associated with depression and post-traumatic stress disorder (PTSD). Some observational research has also reported improvements in depressive and anxiety symptoms following ibogaine treatment.
- Anxiety Disorders – Although research is more limited, preliminary findings suggest that ibogaine may be associated with reductions in anxiety symptoms. Further clinical studies are necessary to determine its effectiveness and safety.
Some of these findings are drawn from a Stanford University study examining the effects of ibogaine treatment in military veterans with traumatic brain injuries and related symptoms. While the results were promising, the study was observational and did not establish that ibogaine caused the reported improvements.
Side Effects of Ibogaine
Each person’s experience with ibogaine may vary. Some of the more commonly reported side effects include:
- Nausea and vomiting
- Fatigue and disorientation
- Ataxia (loss of muscle coordination, balance problems, and difficulty walking)
- Tremors and muscle spasms
Additional serious side effects and complications may include:
- Cardiac complications – Dangerous changes in heart rhythm, including QT prolongation and potentially fatal arrhythmias.
- Seizures – Seizure activity and other serious neurological complications.
- Hallucinations – Vivid, dream-like experiences and significant changes in perception.
- Psychological distress – Severe anxiety, frightening psychedelic experiences, paranoia, fear, and agitation.
- Psychosis and mania – Prolonged mood disturbances or psychotic episodes, particularly in vulnerable individuals.
Ibogaine has also been associated with sudden cardiac death, making appropriate medical screening and monitoring especially important. Certain medications and underlying medical conditions can further increase these risks.
If you have taken ibogaine and are experiencing serious symptoms, particularly chest pain, fainting, palpitations, seizures, or severe confusion, seek emergency medical attention immediately. Do not wait for symptoms to worsen.
Ibogaine’s Potential Benefits in Addiction Treatment
Ibogaine is being investigated as a potential treatment for substance use disorders, particularly for its possible effects on cravings and withdrawal symptoms. Researchers are also exploring whether its psychological effects may help individuals address emotional and behavioral patterns associated with substance use.
A literature review published in the Journal of Substance Abuse Treatment noted that available research suggests ibogaine may help reduce withdrawal symptoms and cravings in individuals with substance use disorders. The review also identified possible benefits for depression and trauma-related symptoms. However, the evidence remains limited, and several studies have documented significant toxicity and safety concerns.
Because ibogaine is not approved for addiction treatment in the United States, there are no established FDA-approved treatment protocols or clinical guidelines defining its role in substance use disorder care.
Generally speaking, medication-based interventions for addiction are most effective when integrated into a comprehensive treatment plan that addresses each patient’s medical, psychological, and behavioral health needs. Evidence-based counseling, behavioral therapies, recovery support, and appropriate medical care remain important components of addiction treatment.
International Ibogaine Clinics
Although ibogaine treatment is not legally available as a routine clinical service in the United States, clinics in certain other countries, including Mexico, offer ibogaine-based treatment for substance use disorders and other conditions.
The treatment experience at these clinics can vary considerably depending on location, medical resources, staff qualifications, safety protocols, and regulatory oversight. Not all facilities provide the same level of medical supervision or emergency care.
Individuals considering international ibogaine treatment should carefully evaluate the facility’s medical screening procedures, cardiac monitoring capabilities, emergency response protocols, and clinical credentials. Travel arrangements and treatment scheduling should also be discussed with the patient’s existing healthcare team to avoid interruptions in ongoing addiction treatment.
It Is Imperative That You Consult Your Clinical Team Before Considering Ibogaine Treatment.
Your doctors can help you understand the potential risks, possible benefits, side effects, medication interactions, and medical suitability of ibogaine. Given its potentially life-threatening cardiac complications and limited clinical evidence, ibogaine should not be considered a substitute for established, evidence-based addiction treatment.
